The PI3K pathway is frequently activated in gliomas, particularly higher-grade gliomas, due to gain-of-function mutations in the PIK3CA gene or loss of the tumor suppressor PTEN [41]. The gene discussed is PTEN; the disease is central nervous system cancer.